Vir Bio (VIR) Stock Forecast, Price Target & Predictions
VIR Stock Forecast
Vir Bio stock forecast is as follows: an average price target of $26.60 (represents a 294.66% upside from VIR’s last price of $6.74) and a rating consensus of 'Buy', based on 10 wall street analysts offering a 1-year stock forecast.
VIR Price Target
VIR Analyst Ratings
Buy
Vir Bio Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Aug 02, 2024 | Gena Wang | Barclays | $28.00 | $9.73 | 187.77% | 315.43% |
Jun 05, 2024 | Michael Ulz | Morgan Stanley | $15.00 | $12.66 | 18.48% | 122.55% |
May 21, 2024 | Gena Wang | Barclays | $27.00 | $9.69 | 178.64% | 300.59% |
Feb 21, 2023 | Paul Choi | Goldman Sachs | $28.38 | $25.74 | 10.26% | 321.07% |
May 06, 2022 | Joseph Stringer | Needham | $35.00 | $21.87 | 60.04% | 419.29% |
10
Vir Bio Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | - | - | 3 |
Avg Price Target | - | - | $23.33 |
Last Closing Price | $6.74 | $6.74 | $6.74 |
Upside/Downside | -100.00% | -100.00% | 246.14% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Aug 02, 2024 | Needham | Buy | Buy | Hold |
Aug 02, 2024 | Barclays | Overweight | Overweight | Hold |
Jun 05, 2024 | Morgan Stanley | Equal-Weight | Equal-Weight | Hold |
Jun 05, 2024 | H.C. Wainwright | Buy | Buy | Hold |
May 21, 2024 | Barclays | Overweight | Overweight | Hold |
May 07, 2024 | Needham | Buy | Buy | Hold |
Mar 15, 2024 | H.C. Wainwright | Underperform | Underperform | Hold |
Mar 15, 2024 | J.P. Morgan | Buy | Buy | Hold |
Sep 08, 2023 | Bank of America Securities | - | Neutral | Downgrade |
Feb 23, 2023 | Goldman Sachs | Buy | Buy | Hold |
10
Vir Bio Financial Forecast
Vir Bio Revenue Forecast
Quarter
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - | - | - | $56.29M | $2.64M | $3.80M | $46.71M | $21.79M | $371.43M | $-42.69M | $1.23B | $812.75M | $103.62M | $177.07M | $1.98M | $76.37K | $1.93M | $66.99M | $5.72M | $980.00K | $1.40M |
Avg Forecast | $13.60M | $10.98M | $14.61M | $18.21M | $8.17M | $5.54M | $7.53M | $11.71M | $11.18M | $8.71M | $22.39M | $50.15M | $149.61M | $114.22M | $200.72M | $811.05M | $622.96M | $138.25M | $84.56M | $98.64M | $4.81M | $11.01M | $3.90M | $2.90M | $2.57M | $3.75M |
High Forecast | $30.01M | $24.23M | $32.25M | $33.88M | $22.26M | $5.78M | $7.53M | $11.71M | $34.10M | $17.70M | $49.41M | $110.68M | $330.19M | $114.22M | $200.72M | $811.05M | $622.96M | $138.25M | $84.56M | $98.64M | $4.81M | $11.01M | $3.90M | $2.90M | $2.57M | $3.75M |
Low Forecast | $2.48M | $2.00M | $2.66M | $2.55M | $643.19K | $5.31M | $7.53M | $11.71M | $692.44K | $4.25M | $4.08M | $9.14M | $27.27M | $114.22M | $200.72M | $811.05M | $622.96M | $138.25M | $84.56M | $98.64M | $4.81M | $11.01M | $3.90M | $2.90M | $2.57M | $3.75M |
# Analysts | 1 | 1 | 1 | 2 | 4 | 2 | 2 | 2 | 4 | 6 | 3 | 3 | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 4 |
Surprise % | - | - | - | - | - | - | - | - | 5.04% | 0.30% | 0.17% | 0.93% | 0.15% | 3.25% | -0.21% | 1.52% | 1.30% | 0.75% | 2.09% | 0.02% | 0.02% | 0.18% | 17.20% | 1.97% | 0.38% | 0.37% |
Forecast
Vir Bio EBITDA Forecast
Quarter
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 2 | 4 | 2 | 2 | 2 | 4 | 6 | 3 | 3 | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 4 |
EBITDA | - | - | - | - | - | - | - | - | $-114.87M | $-186.73M | $-215.19M | $-130.27M | $-159.38M | $208.55M | $-212.24M | $1.11B | $547.41M | $112.25M | $63.27M | $-167.31M | $1.34M | $-83.16M | $-29.75M | $-75.92M | $-62.46M | $-47.12M |
Avg Forecast | $-5.67M | $-4.58M | $-6.10M | $-7.60M | $-3.41M | $-2.31M | $-3.14M | $-527.51M | $-4.66M | $-3.63M | $-9.34M | $-564.18M | $-62.41M | $-48.94M | $-86.01M | $-603.40M | $-266.94M | $-59.24M | $-36.24M | $-645.35M | $-2.06M | $-4.72M | $-1.67M | $-50.13M | $-1.10M | $-35.82M |
High Forecast | $-1.03M | $-835.05K | $-1.11M | $-1.06M | $-268.32K | $-2.21M | $-3.14M | $-422.01M | $-288.86K | $-1.77M | $-1.70M | $-451.34M | $-11.38M | $-48.94M | $-86.01M | $-482.72M | $-266.94M | $-59.24M | $-36.24M | $-516.28M | $-2.06M | $-4.72M | $-1.67M | $-40.11M | $-1.10M | $-28.65M |
Low Forecast | $-12.52M | $-10.11M | $-13.45M | $-14.13M | $-9.29M | $-2.41M | $-3.14M | $-633.01M | $-14.22M | $-7.38M | $-20.61M | $-677.02M | $-137.75M | $-48.94M | $-86.01M | $-724.08M | $-266.94M | $-59.24M | $-36.24M | $-774.42M | $-2.06M | $-4.72M | $-1.67M | $-60.16M | $-1.10M | $-42.98M |
Surprise % | - | - | - | - | - | - | - | - | 24.64% | 51.38% | 23.04% | 0.23% | 2.55% | -4.26% | 2.47% | -1.84% | -2.05% | -1.89% | -1.75% | 0.26% | -0.65% | 17.63% | 17.82% | 1.51% | 56.75% | 1.32% |
Forecast
Vir Bio Net Income Forecast
Quarter
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 2 | 4 | 2 | 2 | 2 | 4 | 6 | 3 | 3 | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 4 |
Net Income | - | - | - | - | - | - | - | - | $-115.92M | $-163.41M | $-194.78M | $-140.96M | $-101.60M | $175.31M | $-76.49M | $518.62M | $525.25M | $110.43M | $61.81M | $-168.91M | $-298.67 | $-84.61M | $-31.17M | $-77.24M | $-63.77M | $-48.31M |
Avg Forecast | $-119.34M | $-110.35M | $-109.66M | $-105.22M | $-117.86M | $-143.83M | $-122.30M | $-532.55M | $-137.72M | $-164.92M | $-164.44M | $-569.57M | $348.95M | $-69.20M | $44.79M | $-609.17M | $357.78M | $-6.47M | $-65.00M | $-651.51M | $-95.81M | $-81.40M | $-83.92M | $-51.01M | $-90.94M | $-36.72M |
High Forecast | $7.52M | $6.95M | $6.91M | $-94.15M | $-93.72M | $9.06M | $7.71M | $-426.04M | $-118.39M | $-119.94M | $10.36M | $-455.66M | $418.74M | $-69.20M | $44.79M | $-487.33M | $357.78M | $-6.47M | $-65.00M | $-521.21M | $-95.81M | $-81.40M | $-83.92M | $-40.81M | $-90.94M | $-29.38M |
Low Forecast | $-306.60M | $-283.49M | $-281.73M | $-116.30M | $-136.32M | $-369.50M | $-314.20M | $-639.06M | $-154.63M | $-203.09M | $-422.45M | $-683.48M | $279.16M | $-69.20M | $44.79M | $-731.00M | $357.78M | $-6.47M | $-65.00M | $-781.82M | $-95.81M | $-81.40M | $-83.92M | $-61.21M | $-90.94M | $-44.07M |
Surprise % | - | - | - | - | - | - | - | - | 0.84% | 0.99% | 1.18% | 0.25% | -0.29% | -2.53% | -1.71% | -0.85% | 1.47% | -17.06% | -0.95% | 0.26% | 0.00% | 1.04% | 0.37% | 1.51% | 0.70% | 1.32% |
Forecast
Vir Bio SG&A Forecast
Quarter
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 2 | 4 | 2 | 2 | 2 | 4 | 6 | 3 | 3 | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 4 |
SG&A | - | - | - | - | - | - | - | - | $43.09M | $41.08M | $47.10M | $46.78M | $38.74M | $43.17M | $41.59M | $38.26M | $55.78M | $50.50M | $28.78M | $25.74M | $70.94K | $18.86M | $16.39M | $12.65M | $11.81M | $9.22M |
Avg Forecast | $152.88M | $123.43M | $164.28M | $204.74M | $91.79M | $62.28M | $84.59M | $131.66M | $125.62M | $97.93M | $251.66M | $563.73M | $37.06M | $1.28B | $2.26B | $92.83M | $7.00B | $1.55B | $950.58M | $1.11B | $54.11M | $123.72M | $43.79M | $32.60M | $28.87M | $42.20M |
High Forecast | $337.39M | $272.41M | $362.55M | $380.81M | $250.23M | $64.92M | $84.59M | $131.66M | $383.27M | $198.92M | $555.41M | $1.24B | $44.47M | $1.28B | $2.26B | $111.39M | $7.00B | $1.55B | $950.58M | $1.11B | $54.11M | $123.72M | $43.79M | $32.60M | $28.87M | $42.20M |
Low Forecast | $27.87M | $22.50M | $29.95M | $28.68M | $7.23M | $59.64M | $84.59M | $131.66M | $7.78M | $47.82M | $45.88M | $102.76M | $29.64M | $1.28B | $2.26B | $74.26M | $7.00B | $1.55B | $950.58M | $1.11B | $54.11M | $123.72M | $43.79M | $32.60M | $28.87M | $42.20M |
Surprise % | - | - | - | - | - | - | - | - | 0.34% | 0.42% | 0.19% | 0.08% | 1.05% | 0.03% | 0.02% | 0.41% | 0.01% | 0.03% | 0.03% | 0.02% | 0.00% | 0.15% | 0.37% | 0.39% | 0.41% | 0.22% |
Forecast
Vir Bio EPS Forecast
Quarter
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 2 | 4 | 2 | 2 | 2 | 4 | 6 | 3 | 3 | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 4 |
EPS | - | - | - | - | - | - | - | - | $-0.00 | $-1.22 | $-1.45 | $-1.06 | $-0.76 | $1.32 | $-0.58 | $3.93 | $4.01 | $0.85 | $0.48 | $-1.32 | $-0.00 | $-0.67 | $-0.27 | $-0.71 | $-0.69 | $-0.44 |
Avg Forecast | $-0.87 | $-0.81 | $-0.80 | $-0.77 | $-0.86 | $-1.05 | $-0.89 | $-1.05 | $-1.01 | $-1.21 | $-1.20 | $-0.87 | $-0.35 | $-0.51 | $0.33 | $3.78 | $2.63 | $-0.05 | $-0.48 | $-0.21 | $-0.70 | $-0.60 | $-0.62 | $-0.53 | $-0.67 | $-0.69 |
High Forecast | $0.06 | $0.05 | $0.05 | $-0.69 | $-0.69 | $0.07 | $0.06 | $0.07 | $-0.87 | $-0.88 | $0.08 | $0.06 | $0.02 | $-0.51 | $0.33 | $3.78 | $2.63 | $-0.05 | $-0.48 | $-0.21 | $-0.70 | $-0.60 | $-0.62 | $-0.53 | $-0.67 | $-0.69 |
Low Forecast | $-2.24 | $-2.07 | $-2.06 | $-0.85 | $-1.00 | $-2.70 | $-2.30 | $-2.70 | $-1.13 | $-1.49 | $-3.09 | $-2.25 | $-0.89 | $-0.51 | $0.33 | $3.78 | $2.63 | $-0.05 | $-0.48 | $-0.21 | $-0.70 | $-0.60 | $-0.62 | $-0.53 | $-0.67 | $-0.69 |
Surprise % | - | - | - | - | - | - | - | - | 0.00% | 1.01% | 1.20% | 1.21% | 2.19% | -2.60% | -1.76% | 1.04% | 1.53% | -17.89% | -1.01% | 6.20% | 0.00% | 1.12% | 0.44% | 1.35% | 1.03% | 0.64% |
Forecast
Vir Bio Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
CVAC | CureVac | $2.49 | $29.00 | 1064.66% | Buy |
VIR | Vir Bio | $6.74 | $26.60 | 294.66% | Buy |
DAWN | Day One Biopharmaceuticals | $13.62 | $38.80 | 184.88% | Buy |
TERN | Terns Pharmaceuticals | $5.60 | $14.25 | 154.46% | Buy |
VKTX | Viking Therapeutics | $51.53 | $102.40 | 98.72% | Buy |
AKRO | Akero Therapeutics | $30.64 | $46.00 | 50.13% | Buy |
AMLX | Amylyx Pharmaceuticals | $5.23 | $6.67 | 27.53% | Buy |
BPMC | Blueprint Medicines | $94.81 | $109.71 | 15.72% | Buy |
PTCT | PTC Therapeutics | $41.96 | $46.50 | 10.82% | Hold |
KRYS | Krystal Biotech | $178.10 | $191.00 | 7.24% | Buy |
MDGL | Madrigal Pharmaceuticals | $317.09 | $315.75 | -0.42% | Buy |
KRTX | Karuna Therapeutics | $329.83 | $257.50 | -21.93% | Buy |